3CE EYEBROW MASCARA GOLD BROWN

Manufacturer
Nanda Co., Ltd | Cosmax, Inc.
Effective date
2016-10-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:47:30

Label at a glance#

Product3CE EYEBROW MASCARA GOLD BROWN
Active ingredientTitanium Dioxide
Label structure6 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Titanium Dioxide 3.2%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Water, Talc, Methyl Trimethicone, Cyclopentasiloxane, Iron Oxides (CI 77492), Trimethylsiloxysilicate, Nylon-12, Acrylates/Stearyl Acrylate/Dimethicone Methacrylate Copolymer, PEG-10 Dimethicone, Butylene Glycol, Iron Oxides (CI 77491), Iron Oxides (CI 77499), Magnesium Sulfate, Mica (CI 77019), Synthetic Fluorphlogopite, DisteardimoniumHectorite, Vinyl Dimethicone/MethiconeSilsesquioxaneCrosspolymer, 1,2-Hexanediol, Lauryl PEG-9 PolydimethylsiloxyethylDimethicone, Triethoxycaprylylsilane, Potassium Sorbate, Phenoxyethanol, Dimethicone, DimethiconeCrosspolymer, Disodium EDTA, Hydrogenated Castor Oil Isostearate

PURPOSE

OTC - PURPOSE SECTION

Purpose: Sunscreen

CAUTION

WARNINGS SECTION

CAUTION: 1. Discontinue use and consult a doctor when - your skin irritates, swells, itches, shows spots on areas applied - your skin reacts similarly with above when exposed to sunlight 2. Avoid applying on wounded, irritated, troubled areas 3. After the use - keep the cap closed - keep it out of children's reach - keep it away from expose to sunlight, high and low temperatures

DESCRIPTION

DESCRIPTION SECTION

INSTRUCTIONS: An eyebrow mascara which will groom your brows into shape and match your hair color. Have natural-looking eyebrows with this eyebrow mascara

Directions: Dispense a small amount on to the brush and apply with short section of the brush along the eyebrow texture in the opposite direction. Finish by combing the eyebrows with the long section of the brush.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
60764-096-022020-01-31C16284748780-19d75b9d0-34d2-f424-e053-dadaa90a57cebccd3a57-833c-43fe-9abf-98757cafd879

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60764-096-013CE EYEBROW MASCARA GOLD BROWN6 g in 1 BOTTLELIQUID61
60764-096-023CE EYEBROW MASCARA GOLD BROWN1 in 1 CARTONLIQUID11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60764-0963CE EYEBROW MASCARA GOLD BROWN (TITANIUM DIOXIDE) LIQUID [NANDA CO., LTD]1Legacy NDC, 2 package rows20161012_bccd3a57-833c-43fe-9abf-98757cafd879.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
60764-09660764-096-01, 60764-096-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
Titanium Dioxide15FIX9V2JPACTIB
Water059QF0KO0RIACT
Talc7SEV7J4R1UIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
44449e50-4350-49c8-b4f1-393298c09cd2bccd3a57-833c-43fe-9abf-98757cafd8792016-10-12WarningsExact identifier
spl id: 44449e50-4350-49c8-b4f1-393298c09cd2
spl set id: bccd3a57-833c-43fe-9abf-98757cafd879

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.